INS and diabetes mellitus: Previous meta-analysis studies have reported that having diabetes is associated with a 20–30% increased mortality risk among cancer patients under insulin therapy with long diabetes duration, which was more apparent among liver, breast, endometrial, and colorectal cancer patients [16].